A detailed history of Camber Capital Management LP transactions in Alkermes Plc. stock. As of the latest transaction made, Camber Capital Management LP holds 200,000 shares of ALKS stock, worth $5.93 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
200,000
Holding current value
$5.93 Million
% of portfolio
0.18%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.01 - $28.55 $4.6 Million - $5.71 Million
200,000 New
200,000 $5.6 Million
Q1 2022

May 16, 2022

SELL
$23.07 - $27.99 $30 Million - $36.4 Million
-1,300,000 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$21.47 - $32.08 $30.6 Million - $45.7 Million
-1,425,000 Reduced 52.29%
1,300,000 $30.2 Million
Q3 2021

Nov 15, 2021

SELL
$23.37 - $32.13 $36.8 Million - $50.6 Million
-1,575,000 Reduced 36.63%
2,725,000 $84 Million
Q2 2021

Aug 16, 2021

SELL
$18.78 - $25.15 $24.4 Million - $32.7 Million
-1,300,000 Reduced 23.21%
4,300,000 $105 Million
Q1 2021

May 17, 2021

SELL
$18.21 - $23.2 $20.9 Million - $26.7 Million
-1,150,000 Reduced 17.04%
5,600,000 $105 Million
Q4 2020

Feb 16, 2021

SELL
$15.39 - $22.1 $7.7 Million - $11.1 Million
-500,000 Reduced 6.9%
6,750,000 $135 Million
Q2 2020

Aug 14, 2020

BUY
$13.31 - $19.41 $16 Million - $23.3 Million
1,200,000 Added 19.83%
7,250,000 $141 Million
Q1 2020

May 15, 2020

BUY
$13.06 - $21.24 $25.1 Million - $40.9 Million
1,925,000 Added 46.67%
6,050,000 $87.2 Million
Q4 2019

Feb 14, 2020

BUY
$17.29 - $21.74 $10.8 Million - $13.6 Million
625,000 Added 17.86%
4,125,000 $84.2 Million
Q3 2019

Nov 14, 2019

BUY
$19.51 - $24.28 $64.6 Million - $80.4 Million
3,311,719 Added 1758.92%
3,500,000 $68.3 Million
Q2 2019

Aug 14, 2019

BUY
$21.47 - $37.33 $4.04 Million - $7.03 Million
188,281 New
188,281 $4.24 Million
Q1 2018

May 15, 2018

SELL
$53.61 - $67.26 $21.4 Million - $26.9 Million
-400,000 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$47.69 - $55.39 $19.1 Million - $22.2 Million
400,000
400,000 $21.9 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Camber Capital Management LP Portfolio

Follow Camber Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.